Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 1,391

Document Document Title
WO/2021/036851A1
The present disclosure relates to the technical field of electronic components, and provided therein are a nitrogen-containing compound represented by formula (I), an organic electroluminescent device and a photoelectric conversion devic...  
WO/2021/037179A1
A compound of formula I or a pharmaceutically acceptable salt, solvate, or prodrug thereof, a preparation method therefor, a pharmaceutical composition comprising same, and an application thereof. The compound can be used to prepare a dr...  
WO/2021/021725A1
This disclosure provides compositions of electrochromic dyes, functionalized electrochromic dyes and dye macromers which may be incorporated into electrochromic devices with tailored optical properties. The disclosure provides an electro...  
WO/2020/261021A1
Described are polymerizable fused tricyclic compounds of formula I: wherein R1, R2, R3, m, n, t, and rings B, C, and D are as defined herein. The compounds absorb various wavelengths of ultraviolet and/or visible light (such as high ener...  
WO/2020/248075A1
The current application relates to pyronaridine or 6-chloro-2-methoxyacridine analogs having binding affinity for the ERCC1-XPF hetero-dimerization interface. The compounds can be used for targeting DNA repair in tumor cells via ERCC1-XP...  
WO/2020/243037A1
The disclosure is directed to bisaminoquinolines and bisaminoacridines as autophagy inhibitors for treating cancer and other disease states and conditions.  
WO/2020/237901A1
The present invention relates to the technical field of organic light-emitting materials, and specifically relates to a thermally activated delayed fluorescence blue light material, a synthesis method therefor and use thereof. The therma...  
WO/2020/228359A1
The present invention relates to the field of organic optoelectronic materials, and disclosed are an organic light-emitting material containing tetraphenylbenzene, preparation, and an application. The organic light-emitting material cont...  
WO/2020/232375A1
Compounds of Formulae I, II, their pharmaceutically acceptable salts or esters thereof capable of binding to and modulating the activity of a stimulator of interferon genes (STING) protein are provided. Methods involving compounds of For...  
WO/2020/216708A1
The present invention relates to a compound having the formula (I), an organic semiconducting layer comprising the same, an organic electronic device comprising the same, a display device comprising the same and a lighting device compris...  
WO/2020/212408A1
The present invention relates to an organic semiconducting material comprising a compound comprising at least one dibenzo [c,h) acridine group and at least one CN-group, organic electronic devices comprising the same and display devices ...  
WO/2020/211124A1
The present invention relates to a thermally activated delayed fluorescence material, a preparation method therefor, and an organic light-emitting diode device. The structural general formula of the thermally activated delayed fluorescen...  
WO/2020/211122A1
The present invention relates to a bipolar thermally activated delayed fluorescence material, a preparation method therefor, and an organic electroluminescent diode device. The structure general formula of the bipolar thermally activated...  
WO/2020/211121A1
The present invention relates to a thermally activated delayed fluorescence material, a preparation method therefor, and an organic electroluminescent diode device, the structural general formula of the thermally activated delayed fluore...  
WO/2020/205765A1
The present invention provides photocatalysts, methods for their preparation, and methods for preparing linear polymers with high propagation rate.  
WO/2020/199945A1
The present invention relates to the technical field of medicine, and discloses a compound as shown in formula (I) and a preparation method therefor, a pharmaceutical composition and the use thereof. In particular, further disclosed in t...  
WO/2020/191866A1
A thermally activated delayed fluorescent material having a chemical structural formula (A), the R group being a diphenylamine group. An efficient deep blue thermally activated delayed fluorescent material is produced by using tetrastyre...  
WO/2020/192042A1
Provided are an electroluminescent material, a method for preparing the electroluminescent material, and a light-emitting device containing the electroluminescent material. Strong electron withdrawing groups such as a cyano group, pyridi...  
WO/2020/156360A1
A cholinesterase inhibitor polymorph, wherein specifically disclosed are a succinic octahydroacridine polymorph, a corresponding crystal composition and pharmaceutical composition, and applications thereof. The compound succinic octahydr...  
WO/2020/151799A1
The present invention relates to improved (simplified/easier, more robust and more reproducible) methods for identification of carbohydrates compositions, e.g. out of complex carbohydrate mixtures, as well as the determination of carbohy...  
WO/2020/151804A1
Sulfonated 2(7)-aminoacridone and 1-aminopyrene dyes and their use as fluorescent tags, in particular for carbohydrate analysis The invention relates to fluorescent dyes with multiple negatively charged groups in their ionized form which...  
WO/2020/124771A1
The present invention relates to a thermally activated delayed fluorescent compound, a preparation method therefor and an organic electroluminescent diode device thereof. The thermally activated delayed fluorescent compound has a structu...  
WO/2020/123482A1
Provided herein are small molecule compounds and methods inhibiting human sulfotransferase 1A3 (SULT1A3) using these small molecule compounds. Methods of manufacturing and treatment are also disclosed.  
WO/2020/100013A1
The present invention addresses the problem of providing an organic compound having a small refractive index. The present invention also provides a novel organic compound having a small refractive index and an electron-donating property....  
WO/2020/082601A1
Disclosed are a dark red photothermally activated delayed fluorescence material, a synthesis method therefor and an electroluminescent device. The dark red photothermally activated delayed fluorescence material is a target compound, whic...  
WO/2020/083327A1
Disclosed in the present invention is an organic compound containing a spirobifluorene structure, having a structure as represented by chemical formula (1), wherein Ar1(Ar2)N-(S1)m- and -(S2)n-NAr3(Ar4) are different, and have symmetrica...  
WO/2020/073479A1
The invention relates to the technical field of organic light-emitting materials, in particular to an organic light-emitting compound, a preparation method therefor, and an organic electroluminescent device containing the organic light-e...  
WO/2020/073480A1
The present application relates to the technical field of organic light-emitting materials, and relates in particular to an organic light-emitting compound, a preparation method therefor, and an organic light-emitting device containing t...  
WO/2020/061537A1
Provided are methods for preparing pathogen-inactivated whole blood and other pathogen-inactivated blood product compositions, as well as kits and compositions related thereto.  
WO/2020/056860A1
The invention discloses a 9,10-dihydroacridine derivative represented by formula (I). The compound has an appropriate HOMO energy level that matches an anode and a light-emitting layer when the compound is used as a material of a hole tr...  
WO/2020/048043A1
Disclosed is an aniline compound for preventing or treating a mental disorder. The compound has a structure represented by formula I, and the definition of each substituent is as described in the specification and claims. Also disclosed ...  
WO/2020/050729A1
The invention relates to a radioisotope-labelled compound of quaternary ammonium salt of a polycyclic aromatic amine with formula I, wherein the wavy line indicates a single bond between the non-nodal carbon atom of a polycyclic aromatic...  
WO/2020/020178A1
An organic compound as shown in formula (1). Ar 2 has a structural formula as shown in formula (2), and a plurality of Ar 2 may be the same or different. The compound as shown in formula (1) can be used as a luminescent layer material of...  
WO/2019/207604A1
The present invention underlying this instant application prepares a library based on tacrine, and discloses and claims derivatives of a heterocyclic compound tacrine with the basic molecular formula C13H14NNH2, and the structural formul...  
WO/2019/194136A1
Provided are a photosensitive composition having an excellent sensitivity, a cured film, a method for manufacturing a color filter, a color filter, a solid-state imaging element, and an image display device. The photosensitive compositio...  
WO/2019/176754A1
The present invention provides: a photoelectric conversion element which has a photoelectric conversion film that has a narrow half width of the absorption peak; an imaging element; an optical sensor; and a compound. A photoelectric conv...  
WO/2019/172830A1
The present disclosure concerns use of compounds of formula I, or salts thereof, as reactive matrices for desorption and laser ablation ionization spectrometry. The disclosure further concerns compounds of formula II, or salts thereof, a...  
WO/2019/145375A1
There is provided herein compounds of formula (I) and pharmaceutically-acceptable salts and/or detectably-labelled derivatives thereof, wherein R1 to R3, X, Y, n and m have meanings as provided in the description, together with formulati...  
WO/2019/100061A1
Compounds of Formula I or pharmaceutically acceptable salts or esters thereof capable of binding to and modulating the activity of a stimulator of interferon genes (STING) protein are provided. Methods involving compounds of Formula I as...  
WO/2019/098542A1
The present specification relates to a heterocyclic compound of chemical formula 1 and an organic photoelectric device comprising the same.  
WO/2019/094788A1
The present technology relates to compounds that inhibit human Ly6K and homologs thereof. Also disclosed are methods of using such compounds to: inhibit activity of a Ly6K protein in a cell; decrease migration, colony formation, and/or p...  
WO/2019/085684A1
Disclosed in the present invention are a cyanobenzene-containing or thiocyanobenzene-containing compound and applications thereof in organic electroluminescent devices. The compound is formed by cyanobenzene or thiocyanobenzene groups, h...  
WO/2019/072932A1
The present invention relates to compounds comprising a TAE structure, for use as a layer material for electronic devices, and to an organic electronic device comprising the layer material, and a method of manufacturing the same.  
WO/2019/072928A1
The present invention relates to compounds comprising a TAE structure, for use as a layer material for electronic devices, and to an organic electronic device comprising the layer material, and a method of manufacturing the same.  
WO/2019/046278A1
The present invention relates to payloads containing functionalized platinum-(benz)acridine hybrid agents as cytotoxic warheads and a method of synthesizing the payloads. The payload can be regioselectively conjugated to a biologically a...  
WO/2019/039597A1
Provided is a new donor-acceptor compound that emits light even in a solid state. The present invention provides an organic optical material in which (1) a conjugated molecule that has (a) at least one electron-donating site, (b) at leas...  
WO/2019/036377A1
The present disclosure provides certain tricyclic compounds that are histone methyltransferases G9a and/or GLP inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of G9a and/or GLP such as cancers an...  
WO/2019/020654A1
The present application relates to a spirobifluorene derivative of a specific formula (I) which is suitable for use in electronic devices.  
WO/2019/002190A1
The present application relates to a spirobifluorene derivative of a specific formula (I) which is suitable for use in electronic devices.  
WO/2018/230854A1
The present invention relates to a novel acridine derivative, and an organic electroluminescent device comprising same. The acridine derivative of the present invention has an intramolecular electron donor and electron receptor, and has ...  

Matches 1 - 50 out of 1,391